Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 125,139 | 117,985 | 118,745 | 108,383 | 113,749 |
| Cost of Goods | 96,987 | 92,918 | 93,841 | 84,150 | 87,918 |
| Gross Profit | 28,152 | 25,067 | 24,904 | 24,233 | 25,831 |
| Operating Expenses | 14,939 | 19,345 | 12,945 | 12,761 | 3,345 |
| Operating Income | 14,200 | 6,640 | 12,800 | 11,622 | 23,404 |
| Interest Expense | 2,590 | 2,669 | 2,530 | 1,363 | 2,920 |
| Pre-tax Income | 11,610 | 3,971 | 10,270 | 10,259 | 20,484 |
| Income Tax | 8,824 | 2,962 | 2,053 | 2,052 | 6,540 |
| Net Income Continuous | 2,786 | 1,009 | 8,217 | 8,207 | 13,944 |
| Minority Interests | 98 | 135 | 157 | 102 | -17 |
| Net Income | $2,688 | $874 | $8,060 | $8,105 | $13,537 |
| EPS Basic Total Ops | 0.07 | 0.02 | 0.17 | 0.18 | 0.30 |
| EPS Basic Continuous Ops | 0.06 | 0.02 | 0.18 | 0.18 | 0.32 |
| EPS Diluted Total Ops | 0.06 | 0.02 | 0.17 | 0.18 | 0.30 |
| EPS Diluted Continuous Ops | 0.06 | 0.02 | 0.17 | 0.18 | 0.32 |
| EBITDA(a) | $18,598 | $11,136 | $17,551 | $16,493 | $28,241 |